Biom Therapeutics is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies for brain disorders.
Our mission is to improve human health and quality of life by developing innovative drugs for treating and possibly reversing the effects of hard-to-treat diseases such as rare epilepsies, Alzheimer’s disease and Autism. Biom’s initial focus is on rare pediatric epilepsy such as developmental and epileptic encephalopathies and Angelman syndrome.
Dr. Paul Carney, a tenured professor at Missouri University’s School of Medicine, is a board-certified pediatric neurologist and an expert on CBD’s benefits in treating epilepsy. Building on research he conducted with grants from the state of Florida and the Angelman Syndrome Foundation, Dr. Carney, together with Bobban Subhadra, Ph.D., a drug-discovery and product-development scientist, founded the Company in 2020 to create effective treatments for neurological disorders.
The Company’s lead drug candidate, BIO017, is a cannabidiol (CBD) formulation designed to treat Angelman Syndrome (AS), a genetic, neurological disorder that results in development delays, speech and movement problems, sleep difficulties, and severe seizures. Biom therapeutics has recently applied for Orphan Drug Designation (ODD) for BIO017 from FDA.
Company Details
- Employees
- 1
- Founded
- -
- Address
- 2203 Industrial Blvd, Sarasota,florida 34234,united States
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://biomtherapeutics.com/
- Keywords
- drug development, pediatrics epilepsy, Angelman syndrome, clinical stage biopharmaceutical.
- HQ
- Sarasota, Florida
Biom Therapeutics Questions
Biom Therapeutics's website is http://biomtherapeutics.com/
Biom Therapeutics's LinkedIn profile is https://www.linkedin.com/company/biom-therapeutics
Biom Therapeutics has
1 employees.
View email and phone details for 1
employees at Biom Therapeutics.
Biom Therapeutics's industry is
Pharmaceutical Manufacturing
Biom Therapeutics's top competitors are
Block Drug Company, Inc.,
Mynd Life Sciences Inc.,
Cava Healthcare Inc.,
Biom Pharmaceutical Corporation,
Bloomington Drug,
Biotran Inc,
Bioinnovation Laboratories,
Nexgen Stem,
Black Hills Custom Parts,
Bird Dog Marketing Group, Llc.
Biom Therapeutics's categories are Pharmaceutical Manufacturing
Biom Therapeutics's founding year is 2020
